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E-mail addresses: jbabul@uchile.cl, jbabul@gmail.cEscherichia coli phosphofructokinase-2 (Pfk-2) is a homodimer whose subunits consist of a large
domain and an additional b-sheet that provides the interfacial contacts between the subunits, cre-
ating a b-barrel ﬂattened-like structure with the adjacent subunit’s b-sheet. To determine how the
structural organization of Pfk-2 determines its stability, the reversible unfolding of the enzyme
was characterized under equilibrium conditions by enzymatic activity, circular dichroism, ﬂuores-
cence and hydrodynamic measurements. Pfk-2 undergoes a cooperative unfolding/dissociation pro-
cess with the accumulation of an expanded and unstructured monomeric intermediate with a
marginal stability and a large solvent accessibility with respect to the native dimer.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction These values indicate that in both cases the conserved a/b/aPhosphofructokinase-2 (Pfk-2) from Escherichia coli is a member
of the ribokinase superfamily, a group of sugar and vitamins ki-
nases formed by a common a/b/a domain [1]. In sugar and sugar
phosphates kinases, such as ribokinase [2], tagatose-6-P kinase
[3], 2-keto-3-deoxygluconate kinase [4] and Pfk-2 [5], there is an
additional structure that forms a lid for the active site. This struc-
ture is a four stranded b-sheet inserted non-sequentially near the
N-terminal end of the conserved a/b/a domain. On the other hand,
vitamins and small molecules kinases are mainly formed by the
conserved a/b/a domain since their structures lack the additional
b-sheet structure [6]. Pyridoxal kinases correspond to such kind
of kinases and have been characterized as active monomers [7],
although a dimer can be observed in the protein crystal [8,9].
The guanidine hydrochloride (GdnHCl) induced unfolding of
pyridoxal kinase from human and sheep brain, was reported as a
two-state reversible equilibrium with calculated stability
values of 1.2 kcal mol1 [10] and 1.55 kcal mol1 [11] respectively.chemical Societies. Published by E
Cl, guanidine hydrochloride;
iotreitol; SEC, size exclusion
; DLS, dynamic light scatter-
the middle of the observed
om (J. Babul).domain behaves as single cooperative unit exhibiting a marginal
stability. However, in the case of sugar and sugar phosphate
kinases, such as E. coli Pfk-2, is not known how the b-sheet
insertion cooperates to bring about the stability of the native
structure.
Light scattering and gel ﬁltration analyses [12,13] have shown
that E. coli Pfk-2 is primarily a dimer in solution, which quaternary
structure is required for enzymatic activity [12,14]. As shown by its
crystal structure (PDB ID code 3CQD), each subunit can be divided
in two parts: the conserved a/b/a domain and the additional
b-sheet structural element that protrudes from it. In Pfk-2 and in
close family homologues, the additional b-sheet structure works
as lid for the active site and also creates the interaction surface be-
tween the subunits, forming an intertwined interface denominated
b-clasp [8]. Thus, Pfk-2 seems to be stabilized by two domains: the
b-clasp interface and the conserved a/b/a domain that accounts for
the mayor part of the intermolecular contacts of each subunit. In
this kind of dimers both domains are separated by the active site,
which is mainly self-contained in each subunit [8].
The GdnHCl unfolding of Pfk-2 was recently studied in order to
obtain information regarding the structure of the separated
subunits [14]. The dissociation of the enzyme originates a semi
structured monomer with an expanded volume. However, a
thermodynamic analysis of the unfolded transitions has not been
explored in detail. In this work, we describe the reversible effect
of GdnHCl on the dissociation and unfolding of Pfk-2 followinglsevier B.V. All rights reserved.
M. Baez, J. Babul / FEBS Letters 583 (2009) 2054–2060 2055enzymatic activity, intrinsic tryptophan ﬂuorescence and circular
dichroism. Moreover, the hydrodynamic properties Pfk-2 were fol-
lowed by size exclusion chromatography and dynamic light scat-
tering measurements. The simplest model to describe the global
unfolding of Pfk-2 is a three-state unfolding reaction N2M 2IM 2U,
characterized by a semi-unstructured monomeric intermediate
with an expanded volume. The energetic parameters extracted
from the three-state unfolding model, indicate that the inter-sub-
unit contact between the four-stranded b-sheets extra domain
confers the global stability to Pfk-2 since the isolated subunits
present a reduced stability with respect to the native dimer. Taken
together the physical characteristics of the monomeric intermedi-
ate and its stability, is postulated that the conserved a/b/a domain
and the b-sheet insertion are thermodynamically coupled in the di-
meric structure of Pfk-2.2. Materials and methods
2.1. Pfk-2 puriﬁcation and storage
E. coli Pfk-2 was puriﬁed and stored as described by Cabrera
et al. [15]. Previous to the unfolding or refolding experiments,
the storage buffer was changed to the standard buffer (50 mM Tris
pH 7.8, 5 mM MgCl2 and 10 mM dithiotreitol (DTT)) by using a Hi-
Trap desalting column (Amersham Biosciences, Uppsala, Sweden),
before a 3 h dialysis in the same buffer. The enzyme was concen-
trated by using a centricon-60 concentrator (Amicon, Berverly,
USA). Protein concentration was determined by the Bradford assay
(Bio-Rad) and is expressed in terms of the monomer concentration.
2.2. Pfk-2 unfolding and refolding
For the refolding experiments, the enzyme was ﬁrst exposed to
3 M GdnHCl (Pierce, molecular biology grade) for at least 5 h at
20 C. Under this condition Pfk-2 was completely unfolded, as indi-
cated by its catalytic activity, circular dichroism spectroscopy (CD)
and intrinsic ﬂuorescence measurements. The refolding curve was
obtained diluting the unfolded enzyme to several GdnHCl concen-
trations in the standard buffer. Under these conditions equilibrium
was achieved after 5 h of incubation at 20 C. The unfolding curves
were constructedbydilutingnative Pfk-2 to severalGdnHCl concen-
trations. In this case equilibrium was obtained after 48 h at 20 C.
GdnHCl concentrations were prepared as described by Pace [16].
2.3. Enzyme assays
Phosphofructokinase enzymatic activity was measured spectro-
photometrically by a coupled assay as described by Babul [17]. The
activity assay began by dilution of a 1 ll aliquot containing the en-
zyme and GdnHCl into 700 ll of assay mixture. Since this proce-
dure implies the dilution of GdnHCl, renaturation should be
expected. To determine the renaturation yield of Pfk-2 during the
enzymatic assay, the enzyme was unfolded with GdnHCl and re-
folded into the assay mixture to bring about a protein concentra-
tions of 0.004 lM (the protein concentration used in the coupled
assay). Under these conditions, substrates were added at several
times after refolding was initiated and the enzymatic activity
was followed. The activity was only about 3% with respect to that
measured with samples that were not previously denatured.
2.4. Intrinsic and ANS ﬂuorescence
Measurements were done in a Perkin–Elmer LS 50 spectroﬂuo-
rimeter. Protein samples at several GdnHCl concentrations were
excited at 295 nm to limit the ﬂuorescence to the single trypto-phan per monomer of Pfk-2 (Trp-88). The emission spectra were
recorded from 300 to 480 nm using emission and excitation slits
of 5 nm. Stock 8-anilino-1-naphthalene sulfonic acid (ANS) solu-
tions (Molecular Probes, Eugene, USA) were prepared in methanol
and its concentration was determined using a e of 7800 M1 cm1
at 372 nm. The Pfk-2 samples refolded and unfolded at different
GdnHCl concentrations contained 80 lM ANS. The mixture was
incubated for 48 h in the dark. Samples prepared in this way were
excited at 380 nm and the emission recorded from 400 to 580 nm.
2.5. Circular dichroism spectroscopy
Far UV CD spectra were acquired in a Jasco J600 dichrograph,
employing 1 mm cell. Each spectrum resulted from the accumula-
tion of three scans (bandwidth 1 mm, scan rate 20 nmmin1) be-
tween 210 and 260 nm (the high absorbance of 5–10 mM DTT
did not allow to record spectra below 210 nm).
2.6. Size exclusion chromatography
Size exclusion chromatography (SEC) equilibrium experiments
were performed using a Water Breeze HPLC system equipped with
a Bio-Rad exclusion column (Bio-Sil SEC 250 gel ﬁltration,
300  7.8 mm). The column was equilibrated with 60 ml of the
mobile phase containing 0.2 M KCl in standard buffer with the
same GdnHCl concentration of that of the sample to be injected.
Calibration was performed by using the proteins provided by the
manufacturer of the column (Vitamin B-12, 1.35 kDa, 8.5 Å Stokes
radius (Rs); horse myoglobin, 17 kDa, 19 Å Rs; chicken ovalbumin,
44 kDa, 30.5 Å Rs; bovine gamma globulin, 158 kDa, 41.8 Å Rs; and
bovine thyroglobulin 670 kDa, 85 Å Rs). Protein elution volumes
were converted to Rs values using the linear relationship obtained
with the molecular-mass markers). The column temperature was
adjusted with a water jacket at 20 C. Protein elution was followed
at 220 and 280 nm. The concentration of the injected protein ran-
ged between 2 and 20 lM.
2.7. Dynamic light scattering experiments
The Stokes radius (Rs) of Pfk-2 in 50 mM Tris buffer pH 8, 5 mM
MgCl2, 10 mM DTT incubated at different GdnHCl concentrations
for 24 h at 20 C, was determined by dynamic light scattering
(DLS) using a DynaPro MSTC014 (Protein Solutions, Lakewood,
NJ, USA) at a protein concentration of 14 lM. All solutions were
centrifuged at 13 600g for 30 min prior to data collection. The
protein concentration of the samples was measured before and
after these treatments and no signiﬁcant loss of sample was ob-
served. Data were acquired by accumulation of 18 readings of 5 s
with detector sensitivity set to 80%. The particle size distribution
was calculated by using the ‘regularization’ method provided with
the DYNAMICS software, supplied with the instrument. The resid-
ual scattering intensity (intensity scattered by the protein without
solvent contribution) was also determined.
2.8. Data analysis
CD unfolding curves were analyzed according to a three-sate
model:
N2 ()
K1
2l ()K2 2U
where N2 represents the native state dimer, I is a monomeric inter-
mediate and U, is the unfolded polypeptide.
The changes in the Gibbs energy expressed in the unfolding
sense of the reaction for the intermediate unfolding (DG2) and
the native dimer unfolding (DG1) are deﬁned as DG2 = RT ln K2
2056 M. Baez, J. Babul / FEBS Letters 583 (2009) 2054–2060and DG1 = RT ln K1 respectively, were R is the gas constant in
kcal mol1 K1 and T is the temperature in Kelvin degrees. The
change in free energy is assumed to be a linear function of denatur-
ant molar concentration (D):
DG1 ¼ DGo1 þm1D
DG2 ¼ DGo2 þm2D
where DGoðxÞ is the free energy change extrapolated to zero denatur-
ant concentration and m1 and m2 are the free energy dependence of
the denaturant concentration for the native dimer (DGo1,m1) and the
intermediate (DGo2, m2) respectively. The fraction of unfolded state
(fu), intermediate state (fi) and native state (fn) are related to the
equilibrium constant K1 and K2 by:
fu ¼
K1K2 ð1þ K2Þ þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð1þ K2Þ2 þ 8Pt=K1
q 
4Pt
ð1Þ
fi ¼ fu=K2 ð2Þ
fn ¼ 1 fi  fu ð3Þ
where Pt is the total protein concentration in terms of monomers.
The observed signal (yobs) was assumed to be dependent on the
population of species according to yobs = yufu + yifi + ynfn, where yu,
yi and yn are the speciﬁc signals of the unfolded, intermediate and
native protein, respectively. The dependence of the baseline signal
for the unfolded and native species with the denaturant concentra-
tion was incorporated in the calculation procedure. The energetic
parameters obtained from enzymatic activity and intrinsic ﬂuores-
cence measurements were calculated by ﬁtting the data to a single
transition according to a N2M 2I model as established by Apiyo
et al. [18].
3. Results
3.1. Folding pathway of Pfk-2 under equilibrium conditions
The GdnHCl-induced unfolding of Pfk-2 was followed by CD,
intrinsic ﬂuorescence and enzymatic activity measurements
(Fig. 1). Since the activity recovery after refolding was found to
be at least 90% in the full range of GdnHCl concentrations (inset,
Fig. 1C), we assume that the irreversible formation of aggregates
is not a preferred reaction pathway under our experimental condi-
tions. Two clear transitions separated by a wide plateau are seenGdn
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Fig. 1. Unfolding and refolding of Pfk-2. (A) Relative changes of ellipticity at 222 nm. (B)
the GdnHCl concentration. The empty and ﬁlled symbols correspond to the refolding a
N2M 2IM 2U (A), and N2M 2I (B, C) unfolding models from which the thermodynamic p
emission spectra, respectively, of the (—) native, (–––) refolded and (. . .) unfolded Pfk-
(indicated in the ﬁgure) upon dilution to 0.1 M. Spectra and activity measurements werwhen the secondary structure changes due to unfolding are moni-
tored by CD (Fig. 1A), suggesting the presence of an intermediate
state near to 0.5 M GdnHCl. The ﬁrst transition occurs from 0.15
to 0.4 M GdnHCl with a middle point about 0.23 M at a protein
concentration of 5 lM. This transition accounts for the 70% of the
overall difference between the CD signal of native and unfolded
protein observed at 220 nm. The second transition occurs between
0.8 and 2.8 M GdnHCl, and ends with the total unfolding of the en-
zyme as judged by the CD spectrum of Pfk-2 at 3 M GdnHCl (inset,
Fig. 1A).
Conversely, the unfolding curves followed by the two other
independent structural probes, intrinsic ﬂuorescence (Fig. 1B)
and enzymatic activity (Fig. 1C), show only one transition which
is superposable with the ﬁrst CD transition, but failed to reproduce
the second transition observed from 0.8 to 2.8 M GdnHCl. Conse-
quently, the intermediate accumulated around 0.5 M GdnHCl is
characterized by a residual secondary structure, lack of enzymatic
activity and a non-native environment of Trp-88. The refolding
curves obtained by dilution of the unfolded Pfk-2 from 3 M GdnHCl
show a good superposition with the unfolding curves described
above (Fig. 1A–C). Accordingly, the ﬂuorescence and CD spectra ob-
tained for the native protein were almost completely recovered
after refolding of Pfk-2 to 0.1 M GdnHCl (insets, Fig. 1) indicating
that the unfolding of dimeric Pfk-2 is a fully reversible process.
To test if the ﬁrst transition observed with the loss of secondary
structure represents a concerted unfolding and dissociation steps,
the equilibrium unfolding transitions were assayed using several
protein concentrations. As shown in the inset of Fig. 2, the unfold-
ing transitions followed by enzymatic activity and intrinsic ﬂuores-
cence shifted their guanidine hydrochloride concentration at the
middle of the observed property change (Cm) values to higher con-
centrations of GdnHCl upon increasing the protein concentration.
The ﬁrst transition detected by CD was also shifted to elevated con-
centrations of GdnHCl with increasing protein concentrations. The
second CD transition (Cm  1.5 M GdnHCl) seems not to be af-
fected by the protein concentration (Fig 2).
Therefore, we can conclude that the simplest model to describe
the global unfolding of Pfk-2 is a three-state unfolding reaction
with a monomeric intermediate: N2M 2IM 2U. Table 1 shows
the energetic parameters obtained by ﬁtting the CD data to this
model by the procedure described under Section 2. The change of
free energy associated with the N2M 2I step, DG
o
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unfolding-dissociation coupled process (N2M 2I). The linear regression (r2) values
obtained from the enzymatic activity and intrinsic ﬂuorescence as function of the
logarithm of the protein concentration were 0.968 and 0.958 respectively.
M. Baez, J. Babul / FEBS Letters 583 (2009) 2054–2060 2057was 2.4 kcal mol1. Similar values were obtained for the N2M 2I
step from ﬂuorescence and enzymatic activity measurement
(11.9 ± 0.2 and 12.1 ± 0.6 kcal mol1, respectively). These resultsTable 1
Thermodynamic parameters calculated from the unfolding of Pfk-2 at pH 7.8 and
20 C.
Enzimatic
activitya
Tryptophan
ﬂuorescencea
Circular
dichroismb
N2M 2I N2M 2I N2M 2I IM U
DGo (kcal mol1) 12.1 ± 0.6 11.9 ± 0.2 12.2 ± 0.9 2.4
m (kcal mol1 M1) 19.6 ± 2.2 19.5 ± 0.5 17 ± 2.8 1.66
a Analyzed in terms of a two state (dimer to monomer) transition. Error values
correspond to three or more independent measurements.
b Analyzed in terms of a three state transition with a monomeric intermediate.
Error values correspond to three or more independent measurements.
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Fig. 3. Population fraction of Pfk-2 species and change in the ANS ﬂuorescence area an
ﬂuorescence area (j,h) and the emission maximum (d,s) are plotted as function of th
symbols) equilibrium curves. (B) Fractions of native dimer (—), monomeric intermediate
The simulation was performed using the same protein concentration as in the ANS expeindicate that the global change of the free energy between the na-
tive dimer and the unfolded monomer is about 17 kcal mol1
(DGo2 þ 2DGo2), with the unfolding and dissociation step (N2M I)
contributing with 70% of the overall free energy change. Them-val-
ues obtained for the N2M 2I and IM U steps were 17 ± 2 and
1.7 kcal mol1 M1, respectively. Since the empiric m-value is re-
lated to the difference in accessible surface area between two
states [19], our results indicate that 90% of the total change in
accessible surface area between the native and unfolded state oc-
curs in the ﬁrst step of unfolding, N2M 2I.
As demonstrated from the early studies of Daniel and Weber
[20] the quantum yield of ANS suffers an increment and its emis-
sion maximum shifts to the blue when it binds to solvent exposed
hydrophobic regions in proteins. Fig. 3A shows the variation of the
ANS emission maximum of and its emission area as function of the
GdnHCl concentration. The ANS emission area shows an asymmet-
rical bell-shape dependence with the chaotropic agent concentra-
tion, which was superimposable for the refolding and unfolding
curves. This behavior resembles the fractional population of the
monomeric intermediate (Fig. 3B) calculated from Eqs. (1–3), indi-
cating that the intermediate detected by CD presents a solvent ex-
posed hydrophobic patch observed as an increment of the ANS
emission area. However, it is clear from Fig. 3A that the variation
of the emission maximum does not follow the variation of the
ANS emission area. As is observed from 0.5 to 1.8 M GdnHCl, the
emission maximum value of ANS stays constant at 460 nm and in-
creases to 510 nm at 3 M, with small changes in its emission area.
This behavior suggests the presence of additional intermediate
species, different from the one inferred from the CD and the ANS
ﬂuorescence area measurements, which could accumulate at high-
er GdnHCl concentrations.
3.2. Hydrodynamic characterization of the intermediate obtained in
presence of GdnHCl
SEC and DLS measurements were used to determine the Rs of
the native, intermediate and unfolded species in the unfolding
pathway of Pfk-2. Fig. 4A shows the elution proﬁle of Pfk-2 ob-
tained at different GdnHCl concentrations after injecting a 50 ll
sample of the protein onto a column equilibrated at the same
GdnHCl concentration. The calculated Rs of Pfk-2 at 0 M GdnHCl
was 34.9 Å according to SEC (Fig. 4A) and 36.5 Å according to
DLS measurements (Fig. 5). The elution volume of Pfk-2 increases,
as a single peak, in the short interval before the ﬁrst transition (seeGdnHCl, M
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Fig. 5. Effect of GdnHCl on the hydrodynamic properties of Pfk-2. Pfk-2 elution
volumes obtained by SEC under (h) unfolding and (s) refolding conditions. The
shaded zone represents the pre-transition region observed with the unfolding and
refolding curves of Pfk-2 where an increased elution volume was detected without
the appearance of a second peak. In this region, the Rs radius obtained by DLS (d)
does not show a signiﬁcant variation. The protein concentration was 15 lM in both
experiments.
2058 M. Baez, J. Babul / FEBS Letters 583 (2009) 2054–2060Fig. 4A). For simplicity, we will refer to this species as peak I. How-
ever, as indicated by the shaded area that covers the pre-transition
zone (Fig. 5), the elution volume increment was not correlated
with a decrease of the Rs measured by DLS, suggesting that peakI is not a product of the dissociation of dimeric Pfk-2. This is
consistent with the effect of protein concentration on the equilib-
rium unfolding curves obtained by enzymatic activity and spectro-
scopic measurements, which indicates that the transition between
dimer and monomers does not occur at GdnHCl concentrations
lower than 0.15 M. Therefore, the elution volume increment
obtained by SEC at the pre-transition region could be due to
anomalous protein–matrix interactions and not to a dissociation
event.
Coincident with the ﬁrst transition region (CD signal between
0.15 and 0.5 M GdnHCl) emerges a new peak (peak II) with a Rs
higher than peak I, as indicated by its lower elution volume
(Fig. 4A). The population of peak II increases from 0.15 to 0.5 M
GdnHCl and seems to predominate at 0.5 M, condition under which
the maximum accumulation of the equilibrium intermediate is ob-
tained (Fig. 3). Since unfolding and dissociation of Pfk-2 (N2M 2I)
occurs within this range of GdnHCl concentrations, we tested if
the relative equilibrium population of both species could be mod-
iﬁed by injecting samples of different protein concentrations into
the column (Fig. 4B). With column and samples equilibrated at
0.3 M GdnHCl, the population of peak I increases over peak II upon
increasing the protein concentration from 1 to 18 lM Pfk-2. On the
other hand, at 0.15 M GdnHCl a proportional increment the area of
peak I is observed without changes in the elution volume, support-
ing the fact that peak I corresponds to a dimer and peak II corre-
sponds to the monomeric intermediate (data not shown). Some
chromatograms show minor additional peaks at low elution vol-
umes which could correspond to Pfk-2 aggregates (Fig. 4, panels
at 0, 2.5, and 3 M GdnHCl); however, the presence of these species
was not reproducible.
An increment in Rs from 36.1 ± 0.8 to 37.8 ± 0.8 Å is observed by
DLS measurements (Fig. 5) at the same GdnHCl concentration
interval in which dissociation occurs. In agreement with the DLS
measurements, the elution volume difference between Peak I and
II corresponds to a calculated Rs difference of 2.5 Å. Since the un-
folded state contributes marginally to the total population species
at 0.5 M (Fig. 3), the value obtained by DLS at 0.5 M of GdnHCl
could correspond to the Rs of the monomeric intermediate.
As expected, the complete unfolding of the intermediate pro-
duces a decrement in the elution volume of peak II (as a single
peak) and an increment of the Rs from 38 to 50 ± 2 Å, as mea-
sured by SEC and DLS, respectively (Fig. 5). Coincident with our
M. Baez, J. Babul / FEBS Letters 583 (2009) 2054–2060 2059observations, the calculated Rs of a completely unfolded 33 kDa
polypeptide is 53 Å [21].
4. Discussion
4.1. Intersubunit interactions are determinant for the stability of Pfk-2
A three-state unfolding mechanism for Pfk-2, N2M 2IM 2U,
was inferred from equilibrium conditions where ‘‘I” is a highly
populated monomer characterized by residual secondary structure
and an expanded volume. The N2M 2I transition involves the con-
certed loss of enzymatic activity, native environment around Trp-
88 residue and about 70% of the native secondary structure, as
indicated by the coincidence in the energetic parameters extracted
from these structural probes (Table 1).
The structural properties of the monomeric intermediate sug-
gest that it does not ﬁt into the classic molten globule description
[22,23]. In agreement with the signiﬁcant loss of secondary struc-
ture, the Rs of the monomeric intermediate (38 Å) is about 13 Å
higher than that predicted for a compact monomer of 33 kDa
[21]. Indeed, the difference between the observed and calculated
Rs of this intermediate goes beyond the reported 15% increment
for polypeptides in the molten globule conﬁguration [24]. The
unstructured character of this monomeric intermediate is also re-
ﬂected by them-value of the transition. Theory holds thatm-values
should be approximately proportional to the amount of new sur-
face area, DA(Adenatured  Anative), exposed upon unfolding of the
native state [25]. Using an empiric approximation [19], m-values
ranging from 16.4 to 18.4 kcal mol1 M1 can be approximated
for complete unfolding of Pfk-2. Since the experimental m-values
for N2M 2I and IM U steps were 17 ± 3 kcal mol1 M1 and
1.7 kcal1 mol1 M1, the monomeric intermediate seems highly
hydrated, although the variation of the ANS ﬂuorescence area indi-
cates that a hydrophobic patch remains in its structure. Such kind
of properties corresponds to the so called pre-molten globule
[26,27].
Homologous members of Pfk-2, like ribokinase, tagatose-6-P ki-
nase, and fructokinase, are homodimers stabilized by an interface
created by an orthogonal packing of four-stranded beta-sheets,
the b-clasp. This topology reassembles a ﬂatten b-barrel stabilized
by a bimolecular hydrophobic core [2]. Since, interfaces that mimic
a compact domain suffer concerted unfolding/dissociation
reactions [28–30] it seems unlikely that the isolated subunits of
Pfk-2 preserve the conformation observed in the context of its di-
meric structure. However, the physical characteristics of the mono-
meric intermediate described above, together with the large
m-value associated with its formation, suggest that a portion of
the protein, larger than the polypeptide chain that conforms the
b-clasp interface, could unfold cooperatively with the dissociation
of the Pfk-2 subunits. Therefore, the b-clasp interface and an
important portion of the conserved a/b/a domain of each subunit
could be considered as a single cooperative unit, where the stabil-
ity of both domains inﬂuences each other. To perform a detail
study of the effects of neighbouring domains, one has to study
the domain in isolation as well as in the two domain protein
[31–33]. Isolation of both domains in Pfk-2 and related kinases is
troubled since the b-sheet structure is inserted discontinuously
into the primary sequence of the a/b/a domain.4.2. Comparison between the equilibrium unfolding pathway of Pfk-2
with other members of the of the ribokinase superfamily
Few stability studies have been performed with the ribokinase
superfamily members and hence little is known about the presence
of equilibrium intermediates that could be correlated with thestructural determinants of the conserved a/b/a fold. Mammalian
pyridoxal kinases have been characterized as active monomers
[7] mainly composed by the a/b/a domain since the additional b-
sheet is replaced by a small loop that covers the ATP binding site
[8,9]. Despite of the marginal percentage of identity between the
sequence of pyridoxal kinase and homologues of Pfk-2, the en-
zymes present a good structural superposition when their con-
served a/b/a domains are overlapped [8]. In contrast with the
N2M 2IM 2U equilibrium unfolding mechanism proposed here
for Pfk-2, pyridoxal kinase from human [10] and sheep [11] have
been reported to unfold through a single transition (NM U), with
associated stability values of 2.4 and 1.2 kcal mol1 and m-values
of 2.4 and 1.2 kcal mol1 M1, respectively. However, besides the
reduced stability, the reported m-values obtained for the NM U
transitions are lower than those expected for the full a/b/a domain
unfolding of pyridoxal kinase (expected m-values are about
8.1 kcal mol1 M1 [19]). This observation was not discussed in
the original works, but would indicate the presence of hidden
intermediate(s) in the equilibrium unfolding pathway of pyridoxal
kinase. Interestingly, the monomeric intermediate of Pfk-2 shows a
stability of 2.6 kcal mol1 and am-value of 1.4 kcal mol1 M1 with
respect to the unfolded state, but it is not known if this intermedi-
ate has a structural counterpart in the equilibrium unfolding path-
way of pyridoxal kinase.
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